A Nutrient Cocktail to Protect Against Physical Inactivity
Metabolic Disturbance, Glucose Intolerance, Physical Inactivity
About this trial
This is an interventional basic science trial for Metabolic Disturbance focused on measuring Metabolism, Lipid oxidation, micronutrient cocktail supplementation, physical inactivity, glucose intolerance, oxidative stress
Eligibility Criteria
Inclusion Criteria:
- Healthy male subjects,
- Aged 20-45 years,
- No obesity or excessive thinness with BMI (weight Kg / height m2) between 22 and 27,
- Height (cm) between 158 and 190 cm,
- Certified as healthy by a comprehensive clinical assessment (detailed medical history and complete physical examination): in particular, free from any chronic disease or any acute infectious disease or ENT, neurological, orthopaedic, musculoskeletal and cardiovascular disorders,
- In the active range of population (10000 to 15000 steps/day)
- No contraindication to lidocaïne,
- No allergy to peanuts or soya,
- Non smokers or smoking less than 5 cigarettes/day,
- No alcohol, no drug dependence and no medical treatment,
Regulations
- Having given written informed consent prior to any procedure related to the study,
- Covered by Health Insurance System,
- Not under any administrative or legal supervision,
- Not under guardianship or trusteeship.
Exclusion Criteria:
- Any history or presence of clinically relevant cardiovascular, neurological or ENT, any chronic disease; any acute infectious disease,
- Obesity or excessive thinness,
- Not in the active range of population (<10000 steps/day),
- Ongoing medical treatment,
- Poor tolerance to blood sampling,
- Having given blood (more than 8ml/kg) in a period of 8 weeks or less before the start of the experiment,
- Subject with contraindication to lidocaïne,
- Special food diet, vegetarian or vegan or food supplementation,
- History of food allergy, especially allergy to peanuts or soya,
- A significant history of allergy,
- Positive reaction to any of the following tests: HVA IgM (hepatitis A), HBs antigen (hepatitis B), anti-HVC antibodies (hepatitis C), anti-HIV1+2 antibodies,
- History or presence of drug or alcohol abuse (alcohol consumption > 40 grams/day).
General conditions
- Subject who, in the judgment of the Investigator, is likely to be non-compliant during the study, or unable to cooperate because of a language problem or poor mental development,
- Subject in the exclusion period of a previous study according to applicable regulations,
- Subject who has received more than 4500 Euros within 12 months for being a research subject,
- Subject who cannot be contacted in case of emergency,
- Incarcerated persons,
- Subject under guardianship or trusteeship.
Sites / Locations
- Medes-Imps
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Control
Cocktail intervention
Intervention: Reduction in daily steps up to 2000-3000 steps per day and no structured physical activity + High dose ingestion of fructose (3g/kg/day) glucose (0,5g/kg/day)in the last 10 days of the protocol No cocktail during the protocol Healthy male volunteers in the active range of population (10000 to 15000 steps per day) aged 20-45 years, 22 BMI 27 158 cm height 190 cm, Certified as healthy by a comprehensive clinical assessment.
Intervention: Reduction in daily steps up to 2000-3000 steps per day and no structured physical activity + High dose ingestion of fructose (3g/kg/day) glucose (0,5g/kg/day)in the last 10 days of the protocol + Micronutrient cocktail supplementation with 560,7 mg/ day of polyphenols (3 pills/day), 2,1 g/day of omega-3 fatty-acids (3 pills/day), 168 mg/day of vitamin E and 80µg/day of selenium (1 pill/day) Healthy male volunteers in the active range of population (10000 to 15000 steps per day) aged 20-45 years, 22 BMI 27 158 cm height 190 cm, Certified as healthy by a comprehensive clinical assessment.